Skip to main content
TipRanks
Go Ultimate75% OFF

Lin BioScience, Inc. (6696) Balance Sheet

Lin BioScience, Inc. Balance Sheet

Lin BioScience, Inc.'s total assets for Q2 2026 were NT$26.07B, an increase of 2.53% from the previous quarter. TW:6696 total liabilities were NT$507.38M for the fiscal quarter, a 74.21% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 25.43BNT$ 5.53BNT$ 3.60BNT$ 1.85BNT$ 923.23M
NT$ 291.24MNT$ 173.22MNT$ 167.73MNT$ 116.06MNT$ 470.25M
NT$ 25.13BNT$ 5.35BNT$ 3.43BNT$ 1.74BNT$ 452.98M

Currency in TWD

Lin BioScience, Inc. Liabilities to Assets

010B20B30B0 %20 %40 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets